Sign In
Buy Z
$35.51
-0.86 (-2.36%)
At Close: Jun 03, 2026
Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen for Duchenne Muscular Dystrophy
08:00am, Thursday, 11'th Dec 2025
Designation expands (Z)-Endoxifen program into rare pediatric neuromuscular disease and may qualify Atossa for a future Priority Review Voucher upon approval SEATTLE , Dec. 11, 2025 /PRNewswire/ -- A
Zillow's Potential Is Not Reflected In This Low Price
03:57am, Wednesday, 10'th Dec 2025
Zillow offers the most compelling, lower-risk way to play a housing market rebound, leveraging dominant market share and asset-light operations. Zillow's diversified revenue streams, especially rental
New patent further strengthens global intellectual property estate supporting Atossa's lead program across the breast cancer spectrum and other hormone-driven conditions SEATTLE , Dec. 9, 2025 /PRNews
Zillow economists say the housing market will warm up in 2026, with more sales and modest price growth
08:00am, Thursday, 04'th Dec 2025
Zillow predicts a slight uptick in home sales as pent-up demand meets improved affordability Home values are forecast to rise 1.2% in 2026, with the number of major markets seeing annual price decline
Atossa Therapeutics Details Accelerated FDA Strategy to Advance (Z)-Endoxifen Across Breast Cancer Continuum
08:00am, Thursday, 04'th Dec 2025
Company positioned to pursue expedited regulatory pathways in metastatic, neoadjuvant, and risk-reduction settings SEATTLE , Dec. 4, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Ato
Zillow Group to present at Barclays 23rd Annual Global Technology Conference
04:05pm, Tuesday, 02'nd Dec 2025
SEATTLE , Dec. 2, 2025 /PRNewswire/ -- Zillow Group, Inc. (Nasdaq: Z and ZG), which is transforming the way people buy, sell, rent and finance homes, today announced Zillow Group will present at this
Zillow Group, Inc. (ZG) Presents at UBS Global Technology and AI Conference 2025 Transcript
01:43pm, Tuesday, 02'nd Dec 2025
Zillow Group, Inc. (ZG) Presents at UBS Global Technology and AI Conference 2025 Transcript
CAMBRIDGE, Mass. , Dec. 2, 2025 /PRNewswire/ -- Insilico Medicine ("Insilico"), a global leader in AI-powered drug discovery, and Atossa Therapeutics ("Atossa") (Nasdaq: ATOS), a clinical-stage biopha
Zillow Removes Climate Risk Scores From Home Listings
03:00am, Sunday, 30'th Nov 2025
The scores aimed to predict a property's risk from a fires, floods and storms, but some in the real estate industry as well as homeowners have called them inaccurate.
DeNA (OTCMKTS:DNACF) versus Zillow Group (NASDAQ:Z) Financial Analysis
01:39am, Saturday, 29'th Nov 2025
DeNA (OTCMKTS:DNACF - Get Free Report) and Zillow Group (NASDAQ: Z - Get Free Report) are both computer and technology companies, but which is the superior business? We will compare the two companies
Altech completes final design for SNC UPS battery system ahead of European deployment
08:43am, Thursday, 27'th Nov 2025
Altech Batteries Ltd (ASX:ATC, OTC:ALTHF) has finalised the engineering design for its next-generation sodium-nickel-chloride (SNC) uninterrupted power...
Greatland extends high-grade footprint at West Dome Underground with broad gold-copper hits
08:43am, Thursday, 27'th Nov 2025
Greatland Resources Ltd (AIM:GGP, OTC:GRLGF, ASX:GGP) has strengthened the growth case for its emerging West Dome Underground (WDU) opportunity at Telfer,...
Hong Kong patent grant strengthens Recce Pharmacueticals’ regional strategy and IP footprint
06:33am, Thursday, 27'th Nov 2025
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has secured formal grant of its Patent Family 4 in the Hong Kong Special Administrative Region, with expiry...
Imugene and JW Therapeutics launch collaborative program to bring CD19 CAR-T innovation to solid tumours
05:22am, Thursday, 27'th Nov 2025
Imugene Ltd (ASX:IMU, OTC:IUGNF) has entered a strategic co-development collaboration with JW Therapeutics (Shanghai) Co. LTD (HKEX: 2126) to evaluate a...
Zillow poised for Q4 beat as house market shows signs of recovery
03:30pm, Wednesday, 26'th Nov 2025
Zillow (NASDAQ:Z) is positioned for another quarter of outperformance in the fourth quarter as US housing momentum shows signs of strengthening, according to analysts at Jefferies. The firm repeated i
